Clinical Trial Update: Target Weaning Oxygen to Determine Cafffeine Duration for AOP [Phase 4]

View source ↗

Summary

Phase 4 trial updating caffeine duration based on oxygen weaning in apnea of prematurity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apnea of Prematurity

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: Children's Hospital of Chongqing Medical University | Conditions: Apnea of Prematurity, Caffeine | Phase 4 | Status: COMPLETED